Author： Keenan P.A. Kuhn T.W.
Publisher： Adis International
ISSN： 1172-7047
Source： CNS Drugs, Vol.11, Iss.4, 1999-04, pp. : 245-251
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Neuropsychiatric Adverse Effects of Mefloquine: What Do We Know and What Should We Do?
By Nosten F.
CNS Drugs, Vol. 11, Iss. 1, 1999-01 ,pp. :
Access to resources
Recommend
Do Cholinesterase Inhibitors Have Disease-Modifying Effects in Alzheimer's Disease?
By Giacobini E.
CNS Drugs, Vol. 15, Iss. 2, 2001-01 ,pp. :
Cannabinoids in Multiple Sclerosis: Do They Have a Therapeutic Role?
By Killestein J. Uitdehaag B.M.J. Polman C.H.
Drugs, Vol. 64, Iss. 1, 2004-01 ,pp. :